Viking Therapeutics, Inc. (VKTX) Shareholders’ equity 2016–2025
Viking Therapeutics, Inc. (VKTX) shareholders’ equity at each fiscal year-end, per SEC filings.
$639.1MFY2025 · since FY2016: $8.0M → $639.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $639.1M | -27.4% |
| FY2024 | $880.3M | +152.6% |
| FY2023 | $348.4M | +139.8% |
| FY2022 | $145.3M | -28.0% |
| FY2021 | $201.9M | -17.4% |
| FY2020 | $244.3M | -11.8% |
| FY2019 | $277.1M | -6.9% |
| FY2018 | $297.8M | +2111.5% |
| FY2017 | $13.5M | +67.4% |
| FY2016 | $8.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice